The therapeutic potential of microRNAs: Disease modulators and drug targets

Pharmaceutical Research

Volumn 28, Issue 12, 2011, Pages 3016-3029

  McDermott, Ailbhe M ^a   Heneghan, Helen M ^a   Miller, Nicola ^a   Kerin, Michael J ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

miRNA manipulation; miRNA therapeutics; oncomirs; tumor supressors

Indexed keywords

AROMATASE INHIBITOR; DICER; GEFITINIB; LAPATINIB; LENTIVIRUS VECTOR; LOCKED NUCLEIC ACID; MICRORNA; PACLITAXEL; POLYAMIDOAMINE; RNA INDUCED SILENCING COMPLEX; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADJUVANT THERAPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CHEMOSENSITIVITY; CHRONIC LYMPHATIC LEUKEMIA; DISEASE FREE SURVIVAL; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GLIOBLASTOMA; HEART ARRHYTHMIA; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER FIBROSIS; LUNG NON SMALL CELL CANCER; LYMPHOMA; MANTLE CELL LYMPHOMA; MEDICAL LITERATURE; METASTASIS INHIBITION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; ONCOGENE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE CANCER; PULMONARY HYPERTENSION; RADIOSENSITIVITY; RNA INTERFERENCE; RNA PROCESSING; TUMOR SUPPRESSOR GENE; VIRAL GENE DELIVERY SYSTEM; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTINEOPLASTIC AGENTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER DISEASES; MICRORNAS; NEOPLASMS;

EID: 83555173337     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0550-2     Document Type: Article

References (105)

1. GA Calin CM Croce 2006 MicroRNA signatures in human cancers Nat Rev Cancer 6 11 857 66 17060945 10.1038/nrc1997 1:CAS:528:DC%2BD28XhtFWhs7fM (Pubitemid 44629897)
2. HM Heneghan N Miller MJ Kerin 2010 MiRNAs as biomarkers and therapeutic targets in cancer Curr Opin Pharmacol 10 5 543 50 20541466 10.1016/j.coph.2010. 05.010 1:CAS:528:DC%2BC3cXhtFygurbE Epub 2010 Jun 10
3. A Rodriguez S Griffiths-Jones JL Ashurst A Bradley 2004 Identification of mammalian microRNA host genes and transcription units Genome Res 14 10A 1902 10 15364901 10.1101/gr.2722704 1:CAS:528:DC%2BD2cXotl2hu7w%3D (Pubitemid 39386503)
4. DP Bartel 2004 MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2 281 97 14744438 10.1016/S0092-8674(04)00045-5 1:CAS:528: DC%2BD2cXhtVals7o%3D (Pubitemid 38167318)
5. EP Murchison GJ Hannon 2004 miRNAs on the move: miRNA biogenesis and the RNAi machinery Curr Opin Cell Biol 16 3 223 9 15145345 10.1016/j.ceb.2004.04.003 1:CAS:528:DC%2BD2cXktVCqsLc%3D (Pubitemid 38610401)
6. AJ Lowery N Miller RE McNeill MJ Kerin 2008 MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management Clin Cancer Res 14 2 360 5 18223209 10.1158/1078-0432.CCR-07-0992 1:CAS:528:DC%2BD1cXhtVKisbY%3D (Pubitemid 351226101)
7. KC Miranda T Huynh Y Tay YS Ang WL Tam AM Thomson, et al. 2006 A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes Cell 126 6 1203 17 16990141 10.1016/j.cell.2006.07. 031 1:CAS:528:DC%2BD28XhtVCnsrvI (Pubitemid 44380294)
8. Jackson RJ, Standart N. How do microRNAs regulate gene expression? Sci STKE 2007 Jan 2;2007(367):re1.
9. W Filipowicz SN Bhattacharyya N Sonenberg 2008 Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9 2 102 14 18197166 10.1038/nrg2290 1:CAS:528:DC%2BD1cXnt1ensA%3D%3D
10. miRBase. University of Manchester; [updated November 2010; cited March 2011]; Release 16.
11. S Volinia GA Calin CG Liu S Ambs A Cimmino F Petrocca, et al. 2006 A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci U S A 103 7 2257 61 16461460 10.1073/pnas.0510565103 1:CAS:528:DC%2BD28XhslGjsbg%3D Epub 006 Feb 3 (Pubitemid 43271657)
12. J Lu G Getz EA Miska E Alvarez-Saavedra J Lamb D Peck, et al. 2005 MicroRNA expression profiles classify human cancers Nature. [Research Support, Non-U.S. Gov't] 435 7043 834 8 1:CAS:528:DC%2BD2MXkvVGgsLc%3D (Pubitemid 40839735)
13. CG Liu GA Calin B Meloon N Gamliel C Sevignani M Ferracin, et al. 2004 An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues Proc Natl Acad Sci U S A 101 26 9740 4 15210942 10.1073/pnas.0403293101 1:CAS:528:DC%2BD2cXlvVaht74%3D Epub 2004 Jun 21 (Pubitemid 38869306)
14. JM Cummins Y He RJ Leary R Pagliarini LA Diaz Jr T Sjoblom, et al. 2006 The colorectal microRNAome Proc Natl Acad Sci U S A 103 10 3687 92 16505370 10.1073/pnas.0511155103 1:CAS:528:DC%2BD28XivFWisrw%3D Epub 2006 Feb 27 (Pubitemid 43376616)
15. PT Nelson DA Baldwin LM Scearce JC Oberholtzer JW Tobias Z Mourelatos 2004 Microarray-based, high-throughput gene expression profiling of microRNAs Nat Methods 1 2 155 61 15782179 10.1038/nmeth717 1:CAS:528:DC%2BD2MXisVGhu7k%3D Epub 2004 Oct 21
16. S Vorwerk K Ganter Y Cheng J Hoheisel PF Stahler M Beier 2008 Microfluidic-based enzymatic on-chip labeling of miRNAs N Biotechnol 25 2-3 142 9 18786664 10.1016/j.nbt.2008.08.005 1:CAS:528:DC%2BD1cXhsVCntLnM Epub 2008 Aug 20
17. Yang JH, Shao P, Zhou H, Chen YQ, Qu LH. deepBase: a database for deeply annotating and mining deep sequencing data. Nucleic Acids Res 38(Database issue):D123-30.
18. MR Friedlander W Chen C Adamidi J Maaskola R Einspanier S Knespel, et al. 2008 Discovering microRNAs from deep sequencing data using miRDeep Nat Biotechnol 26 4 407 15 18392026 10.1038/nbt1394 (Pubitemid 351501815)
19. WC Wang FM Lin WC Chang KY Lin HD Huang NS Lin 2009 miRExpress: analyzing high-throughput sequencing data for profiling microRNA expression BMC Bioinformatics 10 328 19821977 10.1186/1471-2105-10-328
20. M Hackenberg M Sturm D Langenberger JM Falcon-Perez AM Aransay 2009 miRanalyzer: a microRNA detection and analysis tool for next-generation sequencing experiments Nucleic Acids Res 37 Web Server issue W68 76 19433510 10.1093/nar/gkp347 1:CAS:528:DC%2BD1MXosFSrsLs%3D
21. Wang F, Niu G, Chen X, Cao F. Molecular imaging of microRNAs. Eur J Nucl Med Mol Imaging Mar 30.
22. R Spizzo MS Nicoloso CM Croce GA Calin 2009 SnapShot: MicroRNAs in cancer Cell 137 3 586-.e1 10.1016/j.cell.2009.04.040
23. J Weiler J Hunziker J Hall 2006 Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther 13 6 496 502 16195701 10.1038/sj.gt.3302654 1:CAS:528:DC%2BD28XitVGnurg%3D
24. J Elmen M Lindow S Schutz M Lawrence A Petri S Obad, et al. 2008 LNA-mediated microRNA silencing in non-human primates Nature 452 7189 896 9 18368051 10.1038/nature06783 1:CAS:528:DC%2BD1cXkvVSis7w%3D (Pubitemid 351550859)
25. Ebert MS, Sharp PA. Emerging roles for natural microRNA sponges. Curr 20(19):R858-61.
26. MS Ebert JR Neilson PA Sharp 2007 MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells Nat Methods 4 9 721 6 17694064 10.1038/nmeth1079 1:CAS:528:DC%2BD2sXps12gsbo%3D Epub 2007 Aug 12 (Pubitemid 47338166)
27. CM Loya CS Lu D Van Vactor TA Fulga 2009 Transgenic microRNA inhibition with spatiotemporal specificity in intact organisms Nat Methods 6 12 897 903 19915559 10.1038/nmeth.1402 1:CAS:528:DC%2BD1MXhsVWlsLnP Epub 2009 Nov 15
28. Wang Z. The principles of MiRNA-masking antisense oligonucleotides technology. Methods 676:43-9.
29. WY Choi AJ Giraldez AF Schier 2007 Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430 Science 318 5848 271 4 17761850 10.1126/science.1147535 1:CAS:528:DC%2BD2sXhtFCjt7rI Epub 2007 Aug 30 (Pubitemid 47574854)
30. C Li Y Feng G Coukos L Zhang 2009 Therapeutic microRNA strategies in human cancer AAPS J 11 4 747 57 19876744 10.1208/s12248-009-9145-9 1:CAS:528:DC%2BD1MXhsFGmurzF
31. A Colin M Faideau N Dufour G Auregan R Hassig T Andrieu, et al. 2009 Engineered lentiviral vector targeting astrocytes in vivo Glia 57 6 667 79 18942755 10.1002/glia.20795
32. BD Brown MA Venneri A Zingale L Sergi Sergi L Naldini 2006 Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer Nat Med 12 5 585 91 16633348 10.1038/nm1398 1:CAS:528:DC%2BD28Xkt1Kju70%3D Epub 2006 Apr 23
33. P Trang PP Medina JF Wiggins L Ruffino K Kelnar M Omotola, et al. 2010 Regression of murine lung tumors by the let-7 microRNA Oncogene 29 11 1580 7 19966857 10.1038/onc.2009.445 1:CAS:528:DC%2BD1MXhsFWrsbnF
34. D Grimm KL Streetz CL Jopling TA Storm K Pandey CR Davis, et al. 2006 Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways Nature 441 7092 537 41 16724069 10.1038/nature04791 1:CAS:528:DC%2BD28XkvVyku7g%3D (Pubitemid 44050158)
35. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 2 74 108 15761078 10.3322/canjclin.55.2.74 (Pubitemid 40372904)
36. FX Bosch J Ribes R Cleries M Diaz 2005 Epidemiology of hepatocellular carcinoma Clin Liver Dis 9 2 191 211 15831268 10.1016/j.cld.2004.12.009 v
37. E Gottwein BR Cullen 2008 Viral and cellular microRNAs as determinants of viral pathogenesis and immunity Cell Host Microbe 3 6 375 87 18541214 10.1016/j.chom.2008.05.002 1:CAS:528:DC%2BD1cXnvFCnu7Y%3D (Pubitemid 351773098)
38. V Nair M Zavolan 2006 Virus-encoded microRNAs: novel regulators of gene expression Trends Microbiol 14 4 169 75 16531046 10.1016/j.tim.2006.02.007 1:CAS:528:DC%2BD28Xjs1Gltrk%3D
39. S Bala M Marcos G Szabo 2009 Emerging role of microRNAs in liver diseases World J Gastroenterol 15 45 5633 40 19960558 10.3748/wjg.15.5633 1:CAS:528:DC%2BD1MXhsFeru7%2FI
40. WB Jin FL Wu D Kong AG Guo 2007 HBV-encoded microRNA candidate and its target Comput Biol Chem 31 2 124 6 17350341 10.1016/j.compbiolchem.2007.01.005 1:CAS:528:DC%2BD2sXjvF2ktL8%3D Epub 2007 Jan 26 (Pubitemid 46528858)
41. YF Gao L Yu W Wei JB Li QL Luo JL Shen 2008 Inhibition of hepatitis B virus gene expression and replication by artificial microRNA World J Gastroenterol 14 29 4684 9 18698684 10.3748/wjg.14.4684 1:CAS:528: DC%2BD1cXht12ltbfN
42. A Ely T Naidoo S Mufamadi C Crowther P Arbuthnot 2008 Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo Mol Ther 16 6 1105 12 18431360 10.1038/mt.2008.82 1:CAS:528: DC%2BD1cXmt1Ors7o%3D Epub 2008 Apr 22 (Pubitemid 351737076)
43. CL Jopling M Yi AM Lancaster SM Lemon P Sarnow 2005 Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA Science 309 5740 1577 81 16141076 10.1126/science.1113329 1:CAS:528:DC%2BD2MXpsFWisr8%3D (Pubitemid 41266486)
44. JI Henke D Goergen J Zheng Y Song CG Schuttler C Fehr, et al. 2008 microRNA-122 stimulates translation of hepatitis C virus RNA Embo J 27 24 3300 10 19020517 10.1038/emboj.2008.244 1:CAS:528:DC%2BD1cXhtl2gsLnF Epub 2008 Nov 20
45. J Krutzfeldt N Rajewsky R Braich KG Rajeev T Tuschl M Manoharan, et al. 2005 Silencing of microRNAs in vivo with 'antagomirs' Nature 438 7068 685 9 16258535 10.1038/nature04303 Epub 2005 Oct 30 (Pubitemid 41740580)
46. J Elmen H Thonberg K Ljungberg M Frieden M Westergaard Y Xu, et al. 2005 Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality Nucleic Acids Res 33 1 439 47 15653644 10.1093/nar/gki193 1:CAS:528:DC%2BD2MXmsVymsA%3D%3D Print 2005 (Pubitemid 40276964)
47. J Elmen M Lindow A Silahtaroglu M Bak M Christensen A Lind-Thomsen, et al. 2008 Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver Nucleic Acids Res 36 4 1153 62 18158304 10.1093/nar/gkm1113 1:CAS:528:DC%2BD1cXislKiu7k%3D Epub 2007 Dec 23 (Pubitemid 351330933)
48. Y Shan J Zheng RW Lambrecht HL Bonkovsky 2007 Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes Gastroenterology 133 4 1166 74 17919492 10.1053/j.gastro.2007. 08.002 1:CAS:528:DC%2BD2sXht1GltLvN Epub 2007 Aug 3 (Pubitemid 47494462)
49. Y Murakami HH Aly A Tajima I Inoue K Shimotohno 2009 Regulation of the hepatitis C virus genome replication by miR-199a J Hepatol 50 3 453 60 19144437 10.1016/j.jhep.2008.06.010 1:CAS:528:DC%2BD1MXhs1ektrw%3D Epub 2008 Jul 9
50. NC Henderson JP Iredale 2007 Liver fibrosis: cellular mechanisms of progression and resolution Clin Sci (Lond) 112 5 265 80 10.1042/CS20060242 1:CAS:528:DC%2BD2sXhtFWhu7o%3D (Pubitemid 46392114)
51. J Ji J Zhang G Huang J Qian X Wang S Mei 2009 Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation FEBS Lett 583 4 759 66 19185571 10.1016/j.febslet.2009. 01.034 1:CAS:528:DC%2BD1MXitFSls70%3D Epub 2009 Jan 29
52. C Roderburg GW Urban K Bettermann M Vucur H Zimmermann S Schmidt, et al. 2011 Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis Hepatology 53 1 209 18 10.1002/hep. 23922. Epub 2010 Oct 1 20890893 10.1002/hep.23922 1:CAS:528:DC%2BC3MXitVeks7c%3D
53. J Chang E Nicolas D Marks C Sander A Lerro MA Buendia, et al. 2004 miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1 RNA Biol 1 2 106 13 17179747 10.4161/rna.1.2.1066 1:CAS:528:DC%2BD2MXlsFSrt74%3D Epub 2004 Jul 1
54. L Gramantieri M Ferracin F Fornari A Veronese S Sabbioni CG Liu, et al. 2007 Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma Cancer Res 67 13 6092 9 17616664 10.1158/0008-5472.CAN-06-4607 1:CAS:528:DC%2BD2sXnsVyqsbo%3D (Pubitemid 47037488)
55. S Bai MW Nasser B Wang SH Hsu J Datta H Kutay, et al. 2009 MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib J Biol Chem 284 46 32015 27 19726678 10.1074/jbc.M109.016774 1:CAS:528:DC%2BD1MXhtlyjsLfI Epub 2009 Sep 2
56. CJ Lin HY Gong HC Tseng WL Wang JL Wu 2008 miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines Biochem Biophys Res Commun 375 3 315 20 18692484 10.1016/j.bbrc.2008.07.154 1:CAS:528:DC%2BD1cXhtFaqs73K Epub 2008 Aug 8
57. DD Young CM Connelly C Grohmann A Deiters 2010 Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma J Am Chem Soc 132 23 7976 81 20527935 10.1021/ja910275u 1:CAS:528:DC%2BC3cXmt12ms7w%3D
58. Boeri M, Verri C, Conte D, Roz L, Modena P, Facchinetti F, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 108(9):3713-8.
59. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei Y, et al. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest Nov 29.
60. N Yanaihara N Caplen E Bowman M Seike K Kumamoto M Yi, et al. 2006 Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell 9 3 189 98 16530703 10.1016/j.ccr.2006.01.025 1:CAS:528:DC%2BD28XivFWjtLw%3D (Pubitemid 43357945)
61. J Takamizawa H Konishi K Yanagisawa S Tomida H Osada H Endoh, et al. 2004 Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer Res 64 11 3753 6 15172979 10.1158/0008-5472.CAN-04-0637 1:CAS:528:DC%2BD2cXksVKgurs%3D (Pubitemid 38697282)
62. SM Johnson H Grosshans J Shingara M Byrom R Jarvis A Cheng, et al. 2005 RAS is regulated by the let-7 microRNA family Cell 120 5 635 47 15766527 10.1016/j.cell.2005.01.014 1:CAS:528:DC%2BD2MXis1yhsbs%3D (Pubitemid 40343076)
63. A Esquela-Kerscher P Trang JF Wiggins L Patrawala A Cheng L Ford, et al. 2008 The let-7 microRNA reduces tumor growth in mouse models of lung cancer Cell Cycle 7 6 759 64 18344688 10.4161/cc.7.6.5834 1:CAS:528:DC%2BD1cXmvVWqtrk%3D (Pubitemid 351520040)
64. CD Johnson A Esquela-Kerscher G Stefani M Byrom K Kelnar D Ovcharenko, et al. 2007 The let-7 microRNA represses cell proliferation pathways in human cells Cancer Res 67 16 7713 22 17699775 10.1158/0008-5472.CAN-07-1083 1:CAS:528:DC%2BD2sXptVGlsbo%3D (Pubitemid 47281364)
65. MS Kumar SJ Erkeland RE Pester CY Chen MS Ebert PA Sharp, et al. 2008 Suppression of non-small cell lung tumor development by the let-7 microRNA family Proc Natl Acad Sci U S A 105 10 3903 8 18308936 10.1073/pnas.0712321105 1:CAS:528:DC%2BD1cXjs1Ohs7s%3D (Pubitemid 351723497)
66. JB Weidhaas I Babar SM Nallur P Trang S Roush M Boehm, et al. 2007 MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy Cancer Res 67 23 11111 6 18056433 10.1158/0008-5472.CAN-07-2858 1:CAS:528:DC%2BD2sXhtlyiurvI (Pubitemid 350248533)
67. PE Blower JH Chung JS Verducci S Lin JK Park Z Dai, et al. 2008 MicroRNAs modulate the chemosensitivity of tumor cells Mol Cancer Ther 7 1 1 9 18187804 10.1158/1535-7163.MCT-07-0573 1:CAS:528:DC%2BD1cXmsVyiuw%3D%3D
68. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18(3):282-93.
69. Courboulin A, Paulin R, Giguere NJ, Saksouk N, Perreault T, Meloche J, et al. Role for miR-204 in human pulmonary arterial hypertension. J Exp Med 208(3):535-48.
70. MV Iorio M Ferracin CG Liu A Veronese R Spizzo S Sabbioni, et al. 2005 MicroRNA gene expression deregulation in human breast cancer Cancer Res 65 16 7065 70 16103053 10.1158/0008-5472.CAN-05-1783 1:CAS:528:DC%2BD2MXns1WrtL8%3D (Pubitemid 41161233)
71. HM Heneghan N Miller AJ Lowery KJ Sweeney MJ Kerin 2009 MicroRNAs as novel biomarkers for breast cancer J Oncol 2009 950201 19639033 1:STN:280:DC%2BD1MrhvVajsQ%3D%3D
72. DX Nguyen PD Bos J Massague 2009 Metastasis: from dissemination to organ-specific colonization Nat Rev Cancer 9 4 274 84 19308067 10.1038/nrc2622 1:CAS:528:DC%2BD1MXjsFSrsr4%3D
73. Shi M, Liu D, Duan H, Shen B, Guo N. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis. Cancer Metastasis Rev 29(4):785-99.
74. L Ma J Teruya-Feldstein RA Weinberg 2007 Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 7163 682 8 17898713 10.1038/nature06174 1:CAS:528:DC%2BD2sXhtFChurfF (Pubitemid 47552092)
75. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 28(4):341-7.
76. Yan LX, Wu QN, Zhang Y, Li YY, Liao DZ, Hou JH, et al. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res 13(1):R2.
77. Zhang L, Sullivan PS, Goodman JC, Gunaratne PH, Marchetti D. MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. Cancer Res 71(3):645-54.
78. AM Gonzalez-Angulo F Morales-Vasquez GN Hortobagyi 2007 Overview of resistance to systemic therapy in patients with breast cancer Adv Exp Med Biol 608 1 22 17993229 10.1007/978-0-387-74039-3-1 1:CAS:528:DC%2BC3cXhtlKgsb7I
79. Mei M, Ren Y, Zhou X, Yuan XB, Han L, Wang GX, et al. Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells. Technology in Cancer Research & Treatment. [Research Support, Non-U.S. Gov't]. Feb;9(1):77-86.
80. MV Iorio P Casalini C Piovan G Di Leva A Merlo T Triulzi, et al. 2009 microRNA-205 regulates HER3 in human breast cancer Cancer Res 69 6 2195 200 19276373 10.1158/0008-5472.CAN-08-2920 1:CAS:528:DC%2BD1MXjtFyqt78%3D
81. Masri S, Liu Z, Phung S, Wang E, Yuan YC, Chen S. The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells. Breast Cancer Res Treat 124(1):89-99.
82. Zhou M, Liu Z, Zhao Y, Ding Y, Liu H, Xi Y, et al. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. Journal of Biological Chemistry. [Research Support, Non-U.S. Gov't]. Jul 9;285(28):21496-507.
83. Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D, et al. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. Journal of Biological Chemistry. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.]. Jun 4;285(23):17869-79.
84. M Kato T Paranjape RU Muller S Nallur E Gillespie K Keane, et al. 2009 The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells Oncogene 28 25 2419 24 19421141 10.1038/onc.2009.106 1:CAS:528:DC%2BD1MXlsVGmsrg%3D
85. Cittelly DM, Das PM, Spoelstra NS, Edgerton SM, Richer JK, Thor AD, et al. Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. Mol Cancer 9:317.
86. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America. [Comparative Study Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. 2002 Nov 26;99(24):15524-9. (Pubitemid 35403967)
87. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2.[Erratum appears in Proc Natl Acad Sci U S A 2006 Feb 14;103(7):2464]. Proceedings of the National Academy of Sciences of the United States of America. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. 2005 Sep 27;102(39):13944-9.
88. Marcucci G, Mrozek K, Radmacher MD, Garzon R, Bloomfield CD. The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood 117(4):1121-9.
89. Eyholzer M, Schmid S, Wilkens L, Mueller BU, Pabst T. The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. Br J Cancer 103(2):275-84.
90. R Garzon CE Heaphy V Havelange M Fabbri S Volinia T Tsao, et al. 2009 MicroRNA 29b functions in acute myeloid leukemia Blood 114 26 5331 41 19850741 10.1182/blood-2009-03-211938 1:CAS:528:DC%2BC3cXislWrtw%3D%3D
91. A Ota H Tagawa S Karnan S Tsuzuki A Karpas S Kira, et al. 2004 Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma Cancer Res 64 9 3087 95 15126345 10.1158/0008-5472.CAN-03-3773 1:CAS:528:DC%2BD2cXjs1ehtr0%3D (Pubitemid 38581408)
92. L He JM Thomson MT Hemann E Hernando-Monge D Mu S Goodson, et al. 2005 A microRNA polycistron as a potential human oncogene Nature 435 7043 828 33 15944707 10.1038/nature03552 1:CAS:528:DC%2BD2MXkvVGgs70%3D (Pubitemid 40839734)
93. Jiang P, Rao EY, Meng N, Zhao Y, Wang JJ. MicroRNA-17-92 significantly enhances radioresistance in human mantle cell lymphoma cells. Radiat Oncol 5:100.
94. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 17(2):211-5.
95. Takeshita F, Patrawala L, Osaki M, Takahashi RU, Yamamoto Y, Kosaka N, et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 18(1):181-7.
96. Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z, et al. miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. Mol Cell Biochem 350(1-2):207-13.
97. Bo J, Yang G, Huo K, Jiang H, Zhang L, Liu D, et al. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J 278(5):786-92.
98. X Luo H Lin Z Pan J Xiao Y Zhang Y Lu, et al. 2008 Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart J Biol Chem 283 29 20045 52 18458081 10.1074/jbc.M801035200 1:CAS:528:DC%2BD1cXotlOitLg%3D
99. TE Callis K Pandya HY Seok RH Tang M Tatsuguchi ZP Huang, et al. 2009 MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice J Clin Invest 119 9 2772 86 19726871 10.1172/JCI36154 1:CAS:528: DC%2BD1MXhtFWgs7%2FO
100. C Sucharov MR Bristow JD Port 2008 miRNA expression in the failing human heart: functional correlates J Mol Cell Cardiol 45 2 185 92 18582896 10.1016/j.yjmcc.2008.04.014 1:CAS:528:DC%2BD1cXhtVSjs7jN
101. E van Rooij LB Sutherland JE Thatcher JM DiMaio RH Naseem WS Marshall, et al. 2008 Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis Proc Natl Acad Sci U S A 105 35 13027 32 18723672 10.1073/pnas.0805038105
102. R Roshan T Ghosh V Scaria B Pillai 2009 MicroRNAs: novel therapeutic targets in neurodegenerative diseases Drug Discov Today 14 23-24 1123 9 19822222 10.1016/j.drudis.2009.09.009 1:CAS:528:DC%2BD1MXhsV2murjN
103. TF Duchaine FJ Slack 2009 rna interference and micro rna -oriented therapy in cancer: rationales, promises, and challenges Curr Oncol 16 4 61 6 19672426 10.3747/co.v16i4.486 1:STN:280:DC%2BD1MrkvFOhuw%3D%3D
104. PK Mishra N Tyagi M Kumar SC Tyagi 2009 MicroRNAs as a therapeutic target for cardiovascular diseases J Cell Mol Med 13 4 778 89 19320780 10.1111/j.1582-4934.2009.00744.x 1:CAS:528:DC%2BD1MXmt1SmsLk%3D Epub 2009 Mar 13
105. JA Chan AM Krichevsky KS Kosik 2005 MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells Cancer Res 65 14 6029 33 16024602 10.1158/0008-5472.CAN-05-0137 1:CAS:528:DC%2BD2MXmt1eht7c%3D (Pubitemid 40994386)